C. Muller et al., VERAPAMIL DECREASES P-GLYCOPROTEIN EXPRESSION IN MULTIDRUG-RESISTANT HUMAN LEUKEMIC-CELL LINES, International journal of cancer, 56(5), 1994, pp. 749-754
We studied the effect of verapamil on Pgp expression (Pgp) in MDR huma
n leukemia cell lines, K562/ADR and CEM VLB(100). In the K562/ADR cell
line, addition of verapamil to the culture medium (15 mu M concentrat
ion) resulted in a 3-fold decrease in Pgp expression after 72 hr expos
ure. The effect of verapamil was reversible, and Pgp expression reache
d the level of untreated controls 24 hr after discontinuation of verap
amil. Similar results were obtained with the human vinblastine-resista
nt cell line CEM VLB(100). On the contrary, no effect on Pgp expressio
n was observed when the cells were treated with nifedipine or diltiaze
m (2 other calcium-channel blockers), even at doses that inhibited cel
l proliferation. The level of Pgp mRNA in the presence of verapamil wa
s measured by Northern blot and was also decreased 2-fold (with the ma
ximum reached within 24 hr), suggesting a transcriptional or post-tran
scriptional mechanism for verapamil. We further established that the e
ffect of verapamil on Pgp expression led to an increase in DNR and VLB
accumulation and cytotoxicity. These results suggest that verapamil a
cts specifically on Pgp expression in these drug-selected leukemic cel
ls. The identification of a potentially novel mechanism of action may
provide new insights as to how chemosensitization may be more effectiv
ely applied in vivo. (C) 1994 Wiley-Liss, Inc.